Fahrner, J., Michallet, M., Fenwarth, L., Sobh, M., Morisset, S., Deloire, A., Raffoux, E., Botton, S. D., Chantepie, S., Girault, S., Berthon, C., Bertoli, S., Lepretre, S., Dumas, P. Y., Lambert, J., Lebon, D., Pautas, C., Malfuson, J. V., Vey, N., Braun, T., Suarez, F., Schmidt, A., Gressin, R., Bonmati, C., Celli-Lebras, K., Heiblig, M., El-Hamri, M., Preudhomme, C., Dombret, H., Bergeron, A., Duployez, N., Itzykson, R. (2025). Secondary-type acute myeloid leukemia is associated with a higher risk of invasive fungal infection during intensive induction therapy. a correlative study on the ALFA 0702 trial.. Blood. https://doi.org/10.1182/blood-2025-994